The Cardiovascular Risk Factor Profiles among End-stage Renal Failure Patients Treated with Continuous Ambulatory Peritoneal Dialysis and Intermittent Hemodialysis

被引:8
|
作者
Zamiah, S. A. K. Sharifah [1 ]
Draman, Che Rosle [2 ]
Seman, Mohd. Ramli [3 ]
Safhan, A. Fariz [3 ]
Rozalina, R. [2 ]
Ruzni, N. I. Nik [4 ]
机构
[1] Int Islamic Univ Malaysia, Kulliyyah Allied Hlth Sci, Dept Biomed Sci, Pahang, Malaysia
[2] Int Islamic Univ Malaysia, Kulliyyah Med, Dept Internal Med, Pahang, Malaysia
[3] Hosp Tengku Ampuan Afzan, Dept Nephrol, Pahang, Malaysia
[4] Int Islamic Univ Malaysia, Kulliyyah Sci, Pahang, Malaysia
关键词
D O I
10.4103/1319-2442.225185
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular (CV) event is the most common cause of death in dialysis patients. Both traditional and nontraditional CV risk factors related to malnutrition, inflammation, and anemia are commonly found in this population. This study was conducted to evaluate the burden factors of CV risk factors and its management in our regularly dialyzed patients. It was a single-center, cross-sectional analysis of prevalent intermittent hemodialysis (IHD) and continuous ambulatory peritoneal dialysis (CAPD) patients followed up in our hospital. Both the traditional and non-traditional CV risk factors were recorded and compared between the two groups. Eighty-eight patients were recruited. Forty-five were treated with CAPD and 43 patients were treated with IHD. The mean age was 49.5 +/- 15.17 years old and 54.5% were females. Eighty percent were Malay followed by Chinese (14.7%) and Indian (5.7%). Thirty-eight percent were hypertensive and 17% were diabetic. The mean age of CAPD patients was 48.9 +/- 16.9 compared to 50 +/- 13.5 years old for IHD patients (P > 0.05). The body mass index (BMI) of CAPD patients was 23.9 kg/m(2) versus 21.7 kg/m(2) of the IHD (P = 0.04). The systolic and diastolic blood pressure of CAPD patients were 158 and 89 mm Hg in comparison to 141 and 72 mm Hg in IHD patients (P <0.001) and their total and low-density lipoprotein cholesterol level were 5.93 mmol/L and 3.84 mmol/L versus 4.79 mmol/L and 2.52 mmol/L, respectively (P <= 0.001). The CAPD patients were hyperglycemic more than IHD patients, although it was not statistically significant. All the nontraditional CV risk factors except serum albumin were comparable between the two groups. Serum albumin in CAPD patients was 35.5 g/L compared to 40.8 g/L in the IHD patients (P <0.001). In our prevalent dialysis-dependent patients, both traditional and non-traditional CV risk factors are common. Due to the prolonged and continuous glucose exposure from the peritoneal dialysis fluid, the CAPD patients had highly atherogenic serum, higher BMI, and intensified inflammation which pre-disposed them to higher CV events.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 50 条
  • [31] SEVERITY OF LEFT VENTRICULAR HYPERTROPHY AND CARDIOVASCULAR MORTALITY IN END-STAGE RENAL FAILURE PATIENTS UNDERGOING PERITONEAL DIALYSIS AND HEMODIALYSIS
    Rroji , Merita
    Seferi, Saimir
    Cafka, Majlinda
    Spahia, Nereida
    Likaj, Erjola
    Thereska, Nestor
    Barbullushi, Myftar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 488 - 489
  • [32] A study of continuous ambulatory peritoneal dialysis and maintenance hemodialysis in end stage renal disease
    Binu, Upendran
    Vimala, Avadiammal
    Jacob, George
    Kannampyil, Karunan
    Manju, L.
    Ramdas, Pisharody
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 225 - 225
  • [33] SYSTEMIC LUPUS-ERYTHEMATOSUS - ANALYSIS OF DISEASE-ACTIVITY IN 55 PATIENTS WITH END-STAGE RENAL-FAILURE TREATED WITH HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    NOSSENT, HC
    SWAAK, TJG
    BERDEN, JHM
    AMERICAN JOURNAL OF MEDICINE, 1990, 89 (02): : 169 - 174
  • [34] The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis
    Sotirakopoulos, N
    Tsitsios, T
    Stambolidou, M
    Athanasiou, G
    Peiou, M
    Kokkinou, V
    Mavromatidis, K
    RENAL FAILURE, 2004, 26 (02) : 179 - 183
  • [35] Comparison of the risk of de novo cardiovascular disease between hemodialysis and peritoneal dialysis in patients with end-stage renal disease
    Wang, I-Kuan
    Lu, Chi-Yu
    Lin, Cheng-Li
    Liang, Chih-Chia
    Yen, Tzung-Hai
    Liu, Yao-Lung
    Sung, Fung-Chang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 218 : 219 - 224
  • [36] CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS IN DIABETICS WITH END-STAGE RENAL-DISEASE
    AMAIR, P
    KHANNA, R
    LEIBEL, B
    PIERRATOS, A
    VAS, S
    MEEMA, E
    BLAIR, G
    CHISOLM, L
    VAS, M
    ZINGG, W
    DIGENIS, G
    OREOPOULOS, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (11): : 625 - 630
  • [37] CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS IN DIABETICS WITH END-STAGE RENAL-DISEASE
    STROM, L
    HALLAC, RR
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (17): : 1082 - 1082
  • [38] Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy
    Kaptein, EM
    Levenson, H
    Siegel, ME
    Gadallah, M
    Akmal, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09): : 3058 - 3064
  • [39] COMPARISON OF INTERMITTENT (IPD) AND CONTINUOUS (CAPD) PERITONEAL-DIALYSIS IN END-STAGE RENAL
    ATKINS, RC
    THOMSON, NM
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 880 - 880
  • [40] CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS - IMPACT ON MANAGEMENT OF PATIENTS WITH END-STAGE RENAL-DISEASE
    MONCRIEF, JW
    NEPHRON, 1981, 27 (4-5): : 226 - 228